WAM
RPRX icon

World Asset Management’s Royalty Pharma RPRX Stock Holding History

World Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,141
Closed -$211K – 862
2021
Q2 		$211K Sell
5,141
-407
-7% -$17.3K 0.02% 834
2021
Q1 		$244K Buy
+5,548
New +$263K 0.02% 780

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

World Asset Management's RPRX Position: Q3 2021 in Review

World Asset Management sold out of Royalty Pharma (RPRX) in Q3 2021, closing a stake of 5,141 shares — an estimated $211K sold.

World Asset Management first reported a position in RPRX in Q1 2021 and held it in 2 quarters. The position peaked at $244K in Q1 2021. 232 funds tracked by Wall St. Rank hold RPRX as of Q3 2021.

  • World Asset Management reported no remaining Royalty Pharma position as of Q3 2021 after selling out during the quarter.
  • World Asset Management sold 5,141 Royalty Pharma shares in Q3 2021, an estimated $211K.
  • World Asset Management first reported a position in Royalty Pharma in Q1 2021 and held it in 2 quarters.
  • World Asset Management's Royalty Pharma position peaked at $244K in Q1 2021.
  • 232 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.